Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Medhat Askar

Showing results (71-80 of 97) with videos related to

Pageof 10
Sort By:
Transplant International : Official Journal of the European Society for Organ Transplantation|January 10, 2021
A 2020 Banff Antibody-mediatedInjury Working Group examination of international practices for diagnosing antibody-mediated rejection in kidney transplantation - a cohort studyCarrie A Schinstock, Medhat Askar, Serena M Bagnasco, et al.
Human Immunology|September 28, 2019
HLA Haplotypes In 250 Families: The Baylor Laboratory Results And A Perspective On A Core NGS Testing Model For The 17<sup>th</sup> International HLA And Immunogenetics WorkshopMedhat Askar, Abeer Madbouly, Leah Zhrebker, et al.
Blood|January 11, 2014
Identification of a permissible HLA mismatch in hematopoietic stem cell transplantationMarcelo A Fernandez-Viña, Tao Wang, Stephanie J Lee, et al.
Transplantation and Cellular Therapy|October 14, 2020
Specific Class I HLA Supertypes but Not HLA Zygosity or Expression Are Associated with Outcomes following HLA-Matched Allogeneic Hematopoietic Cell Transplant: HLA Supertypes Impact Allogeneic HCT OutcomesChristine Camacho-Bydume, Tao Wang, Jennifer A Sees, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|May 12, 2015
Impact of KIR and HLA Genotypes on Outcomes after Reduced-Intensity Conditioning Hematopoietic Cell TransplantationRonald M Sobecks, Tao Wang, Medhat Askar, et al.
Transplantation and Cellular Therapy|March 30, 2023
HLA Class I Genotype Is Associated with Relapse Risk after Allogeneic Stem Cell Transplantation for NPM1-Mutated Acute Myeloid LeukemiaRupa Narayan, Abhishek Niroula, Tao Wang, et al.
Transplantation and Cellular Therapy|July 6, 2025
Allogeneic Hematopoietic Cell Donor Selection: Contemporary Guidelines from the NMDP/CIBMTRAntonio M Jimenez Jimenez, Stephen R Spellman, Ioannis Politikos, et al.
Clinical Transplantation|April 28, 2025
Rethinking the Diagnosis and Management of Antibody-Mediated Rejection in Multidisciplinary Transplant Meetings: A Global Survey and Banff Working Group RecommendationsRuth Sapir-Pichhadze, Medhat Askar, Matthew Cooper, et al.
Transplantation and Cellular Therapy|August 11, 2021
Influence of Killer Immunoglobulin-Like Receptors and Somatic Mutations on Transplant Outcomes in Acute Myeloid LeukemiaSanghee Hong, Lisa Rybicki, Aiwen Zhang, et al.
Human Immunology|May 25, 2021
High-resolution HLA allele and haplotype frequencies in several unrelated populations determined by next generation sequencing: 17th International HLA and Immunogenetics Workshop joint reportLisa E Creary, Nicoletta Sacchi, Michela Mazzocco, et al.
Pageof 10

Showing results (71-80 of 97) with videos related to

Sort By:
Pageof 10
Transplant International : Official Journal of the European Society for Organ Transplantation|January 10, 2021
A 2020 Banff Antibody-mediatedInjury Working Group examination of international practices for diagnosing antibody-mediated rejection in kidney transplantation - a cohort studyCarrie A Schinstock, Medhat Askar, Serena M Bagnasco, et al.
Human Immunology|September 28, 2019
HLA Haplotypes In 250 Families: The Baylor Laboratory Results And A Perspective On A Core NGS Testing Model For The 17<sup>th</sup> International HLA And Immunogenetics WorkshopMedhat Askar, Abeer Madbouly, Leah Zhrebker, et al.
Blood|January 11, 2014
Identification of a permissible HLA mismatch in hematopoietic stem cell transplantationMarcelo A Fernandez-Viña, Tao Wang, Stephanie J Lee, et al.
Transplantation and Cellular Therapy|October 14, 2020
Specific Class I HLA Supertypes but Not HLA Zygosity or Expression Are Associated with Outcomes following HLA-Matched Allogeneic Hematopoietic Cell Transplant: HLA Supertypes Impact Allogeneic HCT OutcomesChristine Camacho-Bydume, Tao Wang, Jennifer A Sees, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|May 12, 2015
Impact of KIR and HLA Genotypes on Outcomes after Reduced-Intensity Conditioning Hematopoietic Cell TransplantationRonald M Sobecks, Tao Wang, Medhat Askar, et al.
Transplantation and Cellular Therapy|March 30, 2023
HLA Class I Genotype Is Associated with Relapse Risk after Allogeneic Stem Cell Transplantation for NPM1-Mutated Acute Myeloid LeukemiaRupa Narayan, Abhishek Niroula, Tao Wang, et al.
Transplantation and Cellular Therapy|July 6, 2025
Allogeneic Hematopoietic Cell Donor Selection: Contemporary Guidelines from the NMDP/CIBMTRAntonio M Jimenez Jimenez, Stephen R Spellman, Ioannis Politikos, et al.
Clinical Transplantation|April 28, 2025
Rethinking the Diagnosis and Management of Antibody-Mediated Rejection in Multidisciplinary Transplant Meetings: A Global Survey and Banff Working Group RecommendationsRuth Sapir-Pichhadze, Medhat Askar, Matthew Cooper, et al.
Transplantation and Cellular Therapy|August 11, 2021
Influence of Killer Immunoglobulin-Like Receptors and Somatic Mutations on Transplant Outcomes in Acute Myeloid LeukemiaSanghee Hong, Lisa Rybicki, Aiwen Zhang, et al.
Human Immunology|May 25, 2021
High-resolution HLA allele and haplotype frequencies in several unrelated populations determined by next generation sequencing: 17th International HLA and Immunogenetics Workshop joint reportLisa E Creary, Nicoletta Sacchi, Michela Mazzocco, et al.
Pageof 10